#chmp — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #chmp, aggregated by home.social.
-
https://www.europesays.com/dk/90414/ Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class #A/S #Approval #as #by #CHMP #Class #efficacious #EU #First #for #GLP1 #in #Its #most #Nordisk #novo #NovoNordisk #Obesity #Oral #pill #Recommended #representing #semaglutide #the #Treatment #Wegovy
-
https://www.europesays.com/dk/90147/ Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1) #1 #207% #72 #A #A/S #Approval #CHMP #EU #in #Loss #mean #mg #Nordisk #novo #NovoNordisk #of #pen #providing #recommends #SingleDose #to #Up #Wegovy #Weight
-
https://www.europesays.com/dk/89995/ Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® #Approval #CHMP #CopenhagenStockExchange:NOVOB #EMA #InjectableWegovy #NovoNordisk #NovoNordiskA/S #Obesity #PositiveOpinion #SingleDoseDevise #STEPUp #Wegovy72Mg #WegovyHighDose #Wegovy®HD
-
Novo Nordisk A/S: CHMP recommends EU approval of Wegovy®
Wegovy® 7.2 mg in a single-dose pen has now been recommended by CHMP for approval in the EUNovo…
#Europe #EU #approval #CHMP #CopenhagenStockExchange:NOVOB #EMA #EuropeanUnion #injectablewegovy #NovoNordiskA/S #Obesity #positiveopinion #single-dosedevise #STEPup #Wegovy7.2mg #wegovyHD #wegovyHighDose
https://www.europesays.com/europe/50499/ -
Santhera Receives Positive CHMP Opinion to Expand AGAMREE® (vamorolone) Use in Pediatric DMD Patients Aged Two and Older in the EU
Pratteln, Switzerland, April 27, 2026 – Santhera Pharmaceuticals (SIX: SANN) today announced that the Committee for Medicinal Products…
#Europe #EU #EuropeanCommission #(vamorolone) #AGAMREE® #Aged #and #CHMP #DMD #Expand #in #Older #Opinion #Patients #pediatric #Positive #receives #Santhera #the #to #Two #use
https://www.europesays.com/europe/23653/ -
https://www.europesays.com/es/395574/ El CHMP respalda la aprobación de pegunigalsidasa alfa en la enfermedad de Fabry #administración #adoptado #alfa #ampliacion #aprobacion #basa #bright #cada #chmp #comite #Cuatro #datos #decisión #enfermedad #ES #España #Estudio #fabry #farmacocinéticos #ha #Health #humano #integrados #Medicamentos #Opinión #pegunigalsidasa #positiva #posológica #respalda #resultados #Salud #semanas #Spain #uso
-
Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver
-
Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver
-
Patients protest against possible withdrawal of rare liver disease medicine https://www.euractiv.com/section/health-consumers/news/patients-protest-against-possible-withdrawal-of-rare-liver-disease-medicine/?utm_source=dlvr.it&utm_medium=mastodon #CHMP #EASL #EMA #EuropeanMedicinesAgency #liver
-
R to @EMA_News: The 1st gene editing therapy to treat #SickleCellDisease & #BetaThalassemia recommended for approval by EMA's human medicines committee, is also the 1st medicine using a novel gene-editing technology (#CRISPR/Cas9) in the 🇪🇺.
🐦🔗: https://nitter.cz/EMA_News/status/1735660082413592605#m
[2023-12-15 13:56 UTC]
-
R to @EMA_News: The 1st gene editing therapy to treat #SickleCellDisease & #BetaThalassemia recommended for approval by EMA's human medicines committee, is also the 1st medicine using a novel gene-editing technology (#CRISPR/Cas9) in the 🇪🇺.
🐦🔗: https://nitter.cz/EMA_News/status/1735660082413592605#m
[2023-12-15 13:56 UTC]
-
Today’s authorisation by the European Medicines Agency is an important step ahead of winter so that people can increase their protection against RSV.
I encourage Member States to make it available to citizens quickly, especially the most vulnerable.
<div class="rsshub-quote">
EU Medicines Agency: 📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10
</div>🐦🔗: https://n.respublicae.eu/SKyriakidesEU/status/1682382166439673857
-
Today’s authorisation by the European Medicines Agency is an important step ahead of winter so that people can increase their protection against RSV.
I encourage Member States to make it available to citizens quickly, especially the most vulnerable.
<div class="rsshub-quote">
EU Medicines Agency: 📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10
</div>🐦🔗: https://n.respublicae.eu/SKyriakidesEU/status/1682382166439673857
-
📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10🐦🔗: https://n.respublicae.eu/EMA_News/status/1682364425775325184
-
📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10🐦🔗: https://n.respublicae.eu/EMA_News/status/1682364425775325184
-
📢EMA's human medicines committee recommended 14 new medicines for approval in the 🇪🇺, including:
☑️1 vaccine to protect against Respiratory Syncytial Virus #RSV
☑️7 medicines for #cancer
☑️1 medicine to prevent the transmission of #HIV
https://tinyurl.com/yu4kfmp3
#PublicHealth #CHMP https://t.co/EqT4HGfL10🐦🔗: https://n.respublicae.eu/EMA_News/status/1682364425775325184
-
The agenda of EMA's human #medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-17-20-july-2023_en.pdf🐦🔗: https://n.respublicae.eu/EMA_News/status/1680843262297341956
-
The agenda of EMA's human #medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-17-20-july-2023_en.pdf🐦🔗: https://n.respublicae.eu/EMA_News/status/1680843262297341956
-
RT EU Medicines Agency
The agenda of EMA's human medicines committee #CHMP is now published. 💊💉
Find out what medicines will be discussed this month: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-19-22-june-2023_en.pdf
The committee highlights will be released on Friday.🐦🔗: https://n.respublicae.eu/EMA_News/status/1670740308567416837
-
RT EU Medicines Agency
The agenda of EMA's human medicines committee #CHMP is now published. 💊💉
Find out what medicines will be discussed this month: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-19-22-june-2023_en.pdf
The committee highlights will be released on Friday.🐦🔗: https://n.respublicae.eu/EMA_News/status/1670740308567416837
-
RT EU Medicines Agency
The agenda of EMA's human medicines committee #CHMP is now published. 💊💉
Find out what medicines will be discussed this month: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-19-22-june-2023_en.pdf
The committee highlights will be released on Friday.🐦🔗: https://n.respublicae.eu/EMA_News/status/1670740308567416837
-
RT EU Medicines Agency
📢EMA's human medicines committee, the #CHMP, recommended 2⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for the prophylaxis of #migraine
☑️ one medicine for the treatment of chronic #KidneyDisease
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-june-2023
#PublicHealth https://t.co/MmoBuogHs2🐦🔗: https://n.respublicae.eu/EMA_News/status/1672221581534195712
-
RT EU Medicines Agency
📢EMA's human medicines committee, the #CHMP, recommended 2⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for the prophylaxis of #migraine
☑️ one medicine for the treatment of chronic #KidneyDisease
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-19-22-june-2023
#PublicHealth https://t.co/MmoBuogHs2🐦🔗: https://n.respublicae.eu/EMA_News/status/1672221581534195712
-
📢EMA's human medicines committee, the #CHMP, recommended 2 new medicines 💊for approval in the 🇪🇺, including:
☑️ one medicine to diagnose prostate #cancer
☑️ one medicine for the treatment of #epilepsy
#publichealth 👇https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-may-2023🐦🔗: https://n.respublicae.eu/EMA_News/status/1662075982381998081
-
📢EMA's human medicines committee, the #CHMP, recommended 2 new medicines 💊for approval in the 🇪🇺, including:
☑️ one medicine to diagnose prostate #cancer
☑️ one medicine for the treatment of #epilepsy
#publichealth 👇https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-22-25-may-2023🐦🔗: https://n.respublicae.eu/EMA_News/status/1662075982381998081
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉 👇
The committee highlights will be released on Friday.https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-22-25-may-2023_en.pdf
🐦🔗: https://n.respublicae.eu/EMA_News/status/1660574487530598400
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉 👇
The committee highlights will be released on Friday.https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-22-25-may-2023_en.pdf
🐦🔗: https://n.respublicae.eu/EMA_News/status/1660574487530598400
-
📢EMA's human medicines committee, the #CHMP, recommended 7 new medicines for approval in the 🇪🇺, including:
☑️ one vaccine for Respiratory Syncytial Virus #RSV
☑️ three medicines for #cancer
☑️ one medicine for a rare disease #Pompe🐦🔗: https://n.respublicae.eu/EMA_News/status/1651265157538930689
-
📢EMA's human medicines committee, the #CHMP, recommended 7 new medicines for approval in the 🇪🇺, including:
☑️ one vaccine for Respiratory Syncytial Virus #RSV
☑️ three medicines for #cancer
☑️ one medicine for a rare disease #Pompe🐦🔗: https://n.respublicae.eu/EMA_News/status/1651265157538930689
-
📢EMA's human medicines committee, the #CHMP, recommended 7 new medicines for approval in the 🇪🇺, including:
☑️ one vaccine for Respiratory Syncytial Virus #RSV
☑️ three medicines for #cancer
☑️ one medicine for a rare disease #Pompe🐦🔗: https://n.respublicae.eu/EMA_News/status/1651265157538930689
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Wednesday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-24-26-april-2023_en.pdf
🐦🔗: https://n.respublicae.eu/EMA_News/status/1650434887843819520
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Wednesday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-24-26-april-2023_en.pdf
🐦🔗: https://n.respublicae.eu/EMA_News/status/1650434887843819520
-
📢EMA's human medicines committee, the #CHMP, recommended 9⃣ new medicines for approval in the 🇪🇺, including:
☑️ one #COVID19vaccine
☑️ one medicine for #MultipleSclerosis
☑️ one medicine for #Epilepsy🐦🔗: https://n.respublicae.eu/EMA_News/status/1641782170711740416
-
📢EMA's human medicines committee, the #CHMP, recommended 9⃣ new medicines for approval in the 🇪🇺, including:
☑️ one #COVID19vaccine
☑️ one medicine for #MultipleSclerosis
☑️ one medicine for #Epilepsy🐦🔗: https://n.respublicae.eu/EMA_News/status/1641782170711740416
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-27-30-march-2023_en.pdf🐦🔗: https://n.respublicae.eu/EMA_News/status/1640308612072370180
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-27-30-march-2023_en.pdf🐦🔗: https://n.respublicae.eu/EMA_News/status/1640308612072370180
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-27-30-march-2023_en.pdf🐦🔗: https://n.respublicae.eu/EMA_News/status/1640308612072370180
-
📢EMA's human medicines committee, the #CHMP, recommended 8⃣ new #medicines for approval in the 🇪🇺 including:
☑️ three medicines for #cancer
☑️ one medicine for #Fabry disease
☑️ one medicine for facial #angiofibroma
#PublicHealth 👇
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-february-2023🐦🔗: https://n.respublicae.eu/EMA_News/status/1629085367843401732
-
📢EMA's human medicines committee, the #CHMP, recommended 8⃣ new #medicines for approval in the 🇪🇺 including:
☑️ three medicines for #cancer
☑️ one medicine for #Fabry disease
☑️ one medicine for facial #angiofibroma
#PublicHealth 👇
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-february-2023🐦🔗: https://n.respublicae.eu/EMA_News/status/1629085367843401732
-
📢EMA's human medicines committee, the #CHMP, recommended 8⃣ new #medicines for approval in the 🇪🇺 including:
☑️ three medicines for #cancer
☑️ one medicine for #Fabry disease
☑️ one medicine for facial #angiofibroma
#PublicHealth 👇
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-february-2023🐦🔗: https://n.respublicae.eu/EMA_News/status/1629085367843401732
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-february-2023_en.pdf🐦🔗: https://n.respublicae.eu/EMA_News/status/1627646407543848960
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-february-2023_en.pdf🐦🔗: https://n.respublicae.eu/EMA_News/status/1627646407543848960
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉
The committee highlights will be released on Friday.
https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-february-2023_en.pdf🐦🔗: https://n.respublicae.eu/EMA_News/status/1627646407543848960
-
📢EMA's human medicines committee, the #CHMP, recommended 4⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for plaque #psoriasis
☑️ two treatments for #diabetes type 2🐦🔗: https://n.respublicae.eu/EMA_News/status/1618933495983935492
-
📢EMA's human medicines committee, the #CHMP, recommended 4⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for plaque #psoriasis
☑️ two treatments for #diabetes type 2🐦🔗: https://n.respublicae.eu/EMA_News/status/1618933495983935492
-
📢EMA's human medicines committee, the #CHMP, recommended 4⃣ new medicines for approval in the 🇪🇺, including:
☑️ one medicine for plaque #psoriasis
☑️ two treatments for #diabetes type 2🐦🔗: https://n.respublicae.eu/EMA_News/status/1618933495983935492
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-january-2023_en.pdf
The committee highlights will be released on Friday.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1617483638635114496
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-january-2023_en.pdf
The committee highlights will be released on Friday.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1617483638635114496
-
The agenda of EMA's human medicines committee #CHMP is now published.
Find out what medicines will be discussed this month 💊💉: https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-23-26-january-2023_en.pdf
The committee highlights will be released on Friday.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1617483638635114496
-
The #CHMP also recommended to extend the use of #COVID19 vaccine #Spikevax 💉as a booster in children aged 6 to 11 years. ⬇️
🐦🔗: https://n.respublicae.eu/EMA_News/status/1603711320376983556